Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference36 articles.
1. Targeted anticancer therapy: overexpressed receptors and nanotechnology;Akhtar;Clin Chim Acta,2014
2. Computational analysis of quinoline derivatives as potent topoisomerase-II inhibitors;Vaidya;Med Chem Res,2015
3. Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase;Ehmann;Curr Opin Pharmacol,2014
4. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of rigid analogues of 2, 4, 6-trisubstituted pyridine containing 5, 6-dihydrobenzo [h] quinoline Moiety;Jeong;Bull Korean Chem Soc,2011
5. Design, synthesis and antitumor activity of novel link-bridge and b-ring modified combretastatin a-4 (ca-4) analogues as potent antitubulin agents;Duan;Sci Rep,2016
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, spectroscopic characterizations, and biological investigation of oxospiro[chromine-4,3-indolene]-based compounds as promising antiproliferative EGFR inhibitors and antimicrobial agents;Molecular Diversity;2024-06-09
2. Development of 1,5-diarylpyrazoles as EGFR/JNK-2 dual inhibitors: design, synthesis, moleecular docking, and bioactivity evaluation;Bioorganic & Medicinal Chemistry Letters;2024-04
3. Advances in chalcone derivatives: Unravelling their anticancer potential through structure-activity studies;Journal of Molecular Structure;2024-03
4. Design, synthesis, and mechanistic insight of novel imidazolones as potential EGFR inhibitors and apoptosis inducers;Bioorganic Chemistry;2024-03
5. New pyrazolo[3,4-d]pyrimidine derivatives as EGFR-TK inhibitors: design, green synthesis, potential anti-proliferative activity and P-glycoprotein inhibition;RSC Advances;2024